Srdjan Stankovic - Concepedia

Author

Srdjan Stankovic

Acadia Pharmaceuticals (United States)ORCID

Also Known As

S. Stankovic, Srdjan R. Stankovic, Srdjan Stankovic, Stankovic, Srdjan

Publications

628

Citations

H-Index

Concepts

All Affiliations

Acadia Pharmaceuticals (United States)Alkermes (United States)The University of Texas Southwestern Medical Center University of Alabama at Birmingham Parkinson's Research and Education Foundation

About

Srdjan Stankovic is an author at Acadia Pharmaceuticals (United States) specializing in social sciences, psychiatry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Social Sciences	5	5	247
2	Medicine	4	4	93
3	Pharmacology	3	3	80
4	Geography	1	1	35
5	Neurology	1	1	40

Srdjan Stankovic

Publications

578

Citations

H-Index

Page 1

	Year	Citations
SUNtool – A new modelling paradigm for simulating and optimising urban sustainability Darren Robinson, Nittaya Campbell, W. Gaiser, Solar Energy Urban ModellingSustainable DevelopmentEnvironmental PlanningSocial SciencesSustainable Design	2007	159
A Randomized, Double-Blind, Placebo-Controlled Trial of Aripiprazole Lauroxil in Acute Exacerbation of Schizophrenia Herbert Y. Meltzer, Robert Risinger, Henry A. Nasrallah, The Journal of Clinical Psychiatry	2015	113
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY) Maurizio Fava, Bryan Dirks, Marlene P. Freeman, The Journal of Clinical Psychiatry	2019	49
Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosis Clive Ballard, David Kreitzman, Stuart Isaacson, Parkinsonism & Related Disorders Disease PsychosisPsychoactive DrugPsychiatryMedicineLong-term Evaluation	2020	40
Principles of climate sensitive urban design analysis in identification of suitable urban design proposals. Case study: Central zone of Leskovac competition Aleksandra Đjukić, Milena Vukmirović, Srdjan Stankovic Energy and Buildings Urban VulnerabilityUrban GeographyUrban DesignDesignGeography	2015	35
Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia Henry A. Nasrallah, John W. Newcomer, Robert Risinger, The Journal of Clinical Psychiatry	2016	34
Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia Leslie Citrome, Yangchun Du, Robert Risinger, International Clinical Psychopharmacology Psychotropic MedicationPsychopharmacologyMental HealthPsychologySocial Sciences	2015	27
Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients Stuart Isaacson, Clive Ballard, David Kreitzman, Parkinsonism & Related Disorders	2021	22
ENHANCE: Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin for Schizophrenia in Patients With an Inadequate Response to Antipsychotic Treatment Dragana Bugarski‐Kirola, István Bitter, I-Yuan Liu, Schizophrenia Bulletin Open	2022	18
Blinded SAPS-PD Assessment After 10 Weeks of Pimavanserin Treatment for Parkinson’s Disease Psychosis Stuart Isaacson, Bruce Coate, James J. S. Norton, Journal of Parkinson s Disease	2020	16

Page 1